Recruiting Heart Attack Studies in Culver City
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and adolescents....
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
The purpose of this study is to test the long-term safety of rimegepant in the acute treatment of migraine in children and adolescents (≥ 6 to \< 18 years of age)....
About Heart Attack Clinical Trials in Culver City
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
There are currently 2 heart attack clinical trials recruiting participants in Culver City, CA. These studies are seeking a combined 2,700 participants. Research is being sponsored by Pfizer. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Attack Clinical Trials in Culver City — FAQ
Are there heart attack clinical trials in Culver City?
Yes, there are 2 heart attack clinical trials currently recruiting in Culver City, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Culver City?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Culver City research site will contact you about next steps.
Are clinical trials in Culver City free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Culver City studies also compensate for your time and travel.
What heart attack treatments are being tested?
The 2 active trials in Culver City are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.
Data updated March 2, 2026 from ClinicalTrials.gov